Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,270 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

SB497115 (Oral Thrombopoietin Receptor Agonist) Versus Placebo In Adults With Thrombocytopenia Due To Hepatitis C

NCT00110799

Conditions
Blood Platelet Disorders, Blood-Borne Infections, Chronic Disease, +20 more
Locations
  • GSK Investigational Site Denver, Colorado, United States
  • GSK Investigational Site Boston, Massachusetts, United States
  • GSK Investigational Site Detroit, Michigan, United States
  • GSK Investigational Site St Louis, Missouri, United States
View all 30 locations
View Trial Details
Completed

Antiviral Activity of Entecavir in Patients Receiving Liver Transplant Due to Chronic Hepatitis B Virus Infection

NCT00395018

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Northwestern University Chicago, Illinois, United States
  • Tulane University Hospital & Clinic New Orleans, Louisiana, United States
  • Mayo Clinic Rochester, Minnesota, United States
  • University Of Nebraska Medical Center Omaha, Nebraska, United States
View all 32 locations
View Trial Details
Completed

Safety and Efficacy Study of Switching From Epzicom to Truvada

NCT00724711

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • Health For Life Clinic, PLLC Little Rock, Arkansas, United States
  • Vista Medical Partners Beverly Hills, California, United States
  • AHF Beverly Hills, California, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
View all 80 locations
View Trial Details
Completed

Acoustic Radiation Force Impulse-Imaging in Comparison to Transient Elastography for Liver Fibrosis Staging in HCV

NCT01113814

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Bordeaux University Hospital Bordeaux, France
  • Universitätsklinikum Düsseldorf Düsseldorf, Germany
  • Universitätsklinikum Erlangen Erlangen, Germany
  • Klinikum der J.W. Goethe-Universität Frankfurt am Main, Germany
View Trial Details
Completed

A Phase II Study of Intermittent Recombinant Human Interleukin-2 (rhIL-2) by Intravenous or Subcutaneous Administration in Subjects With HIV Infection on Highly Active Antiretroviral Therapy (HAART) Compared to HAART Alone

NCT00000870

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Alabama Therapeutics CRS Birmingham, Alabama, United States
  • USC CRS Los Angeles, California, United States
  • Stanford CRS Palo Alto, California, United States
  • Harbor-UCLA Med. Ctr. CRS Torrance, California, United States
View all 20 locations
View Trial Details

Related conditions